Signal Detection and Clarification of Peripheral Neuropathy and Guillain-Barré Syndrome Associated with Exposure to Systemic Fluoroquinolones

Journal Title: Journal of Pharmaceutical Research International - Year 2014, Vol 4, Issue 4

Abstract

Aims: Peripheral neuropathy (PN) is an identified risk of systemic antibacterial therapy with fluoroquinolones. The risk and its severity, including the development of Guillain-Barré syndrome (GBS) between individual agents is uncertain. This study examines the association between fluoroquinolones and PN and GBS in cases spontaneously reported to the FDA Adverse Event Reporting System (FAERS). Study Design: Retrospective pharmacovigilance analysis. Place and Duration of Study: Cases submitted to FAERS between 1997 and 2012. Methodology: The MedDRA Preferred Term was used to define PN and GBS. Individual fluoroquinolones were identified by generic names and route of administration. Empirical Bayes Geometric Mean (EBGM) with 95% confidence interval (EB05-EB95) was calculated as disproportionality measure. Safety signals with EB05>2 was considered a significant disproportional increase in event reporting of at least twice times higher than expected. Results: There were 539 PN reports out of 46,257 adverse event reports submitted for fluoroquinolones. 9% of PN reports were for GBS. Significant disproportionality of PN (EBGM 2.70; EB05-EB95 2.51-2.90) and GBS (EBGM 3.22; EB05-EB95 2.55-4.02) was identified for fluoroquinolones. Signals of PN were detected for ciprofloxacin (EBGM 3.24; EB05-EB95 2.87-3.66) and levofloxacin (EBGM 3.36; EB05-EB95 3.02-3.72). A GBS signal was detected for ciprofloxacin (EBGM 4.15; EB05-EB95 2.94-5.74). GBS and PN respectively ranked 6th and 8th among reported neurological events. Conclusion: This study reemphasizes the link between fluoroquinolones and PN, and shows potential association with more severe forms of nerve damage, e.g. GBS. Unless the benefit of fluoroquinolone therapy outweighs PN risk, treatment with alternative antibacterial agents is recommended.

Authors and Affiliations

Ayad K. Ali

Keywords

Related Articles

Evaluation of Antioxidant and Antiacne Activity of Psorospermum febrifugum (Spach) and Psorospermum corymbiferum (Hochr.)

Aim: This study investigated the anti-acne activity, lipase inhibitory effects and antioxidant property of Psorospermum febrifugum and Psorospermum corymbiferum of the family Hypericaceae. Study Design: Antimicrobial as...

Antioxidant and Hepatoprotective Activity of Ethanol Extract of Valeriana wallichii in CCl4 Treated Rats

Aims: To screen the hepatoprotective and antioxidant activity of ethanol extract of roots of Valeriana wallichii DC (Valerianaceae)(VWE). Study Design: Animal study. Place and Duration of Study: Department of Pharmacolog...

Awareness of Human Papillomavirus (HPV) among School Children in Johor, Malaysia

Aims: The aim of this study was to assess the understanding of human papillomavirus (HPV) infection, knowledge of HPV vaccination as well as acceptance of the HPV vaccination among female secondary school students in Kot...

Synthesis, Docking Study and Antifungal Activity Evaluation of Some 1,3-benzo[d]thiazole Analogs: A Promotion in Synthetic Method with Nano-γ-Al2O3/BF3-n under Solvent Free Conditions

Aim: Nano-γ-Al2O3/BF3-n was applied for the synthesis of 1,3-benzo[d]thiazole derivatives as a new solid acid catalyst. Benzothiazole is used as a pharmacological agent with a wide variety of biological activities such a...

Study of Preventive Effectiveness of Nigella sativa L. against Rat kidney Stones, Generated by Ethylene Glycol

Aims: The objective of this research is to study the preventive effectiveness of Nigella sativa L. against rat kidney stones, generated by Ethylene Glycol. Methodology: In this study, 40 Wistar rats were categorized r...

Download PDF file
  • EP ID EP344673
  • DOI 10.9734/BJPR/2014/6954
  • Views 73
  • Downloads 0

How To Cite

Ayad K. Ali (2014). Signal Detection and Clarification of Peripheral Neuropathy and Guillain-Barré Syndrome Associated with Exposure to Systemic Fluoroquinolones. Journal of Pharmaceutical Research International, 4(4), 407-417. https://europub.co.uk/articles/-A-344673